Delivery Order SPE2DB24D3013-SPE2DB24FFGBS

Award Date 7/5/24
Potential Completion Date 7/8/24
Potential Value $8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,864.91, is a Firm Fixed Price Delivery Order for the supply of PROCARDIA XL 90 MG TABLET 100S. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor, and there is no information provided about any major subcontractors. The contract has an ultimate...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of NORVASC 5 MG TABLET UD 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical is valued at up to $999,999,999.00 through December 31, 2025, serving as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office division is for the delivery of Corlanor 5 mg tablets, a prescription pharmaceutical product, to the Defense Logistics Agency (DLA). The $6,242.76 firm-fixed-price delivery order has a completion date of June 27, 2024. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,151.72 delivery order contract is for the supply of NORPACE CR 100 MG CAPSULE 100S, a cardiovascular medication. The contract has a firm fixed price and an ultimate completion date of December 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,491.24 firm fixed-price delivery order is for the supply of 4,564,528,683 units of the medication Procainamide 1,000 mg/10 ml vial. The contract has an ultimate completion date of May 8, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA through December...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, is for the delivery of a wide range of prescription medications, over-the-counter drugs, and medical supplies to the U.S. government. The $6,388.32 firm fixed-price delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $46,094.81 for the provision of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of June 24, 2024 and is a firm fixed-price agreement. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA valued at up to...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $14,280.73, is for the delivery of Cardizem CD 360 mg capsules. It is a firm fixed-price delivery order contract with a completion date of September 27, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by various defense...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the procurement of a variety of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. The...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of pharmaceutical products and medical supplies to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA valued at up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, Amerisourcebergen will provide a comprehensive range of medications, including specialty, brand name, generic,...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB24FFGBS
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,077,737 units of PROCARDIA XL 60 MG TABLET 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $7,998.30, has a period of performance through July 8, 2024.

Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Additionally, Amerisourcebergen holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. The contract has no set-aside designation.

Generated 10/4/24, 9:07 AM